1 year return (CAGR)
148.29%
Galmed Pharmaceuticals Ltd Exchange (NASDAQ, USD)
GLMD
3.62
+0.13 (+3.57%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-25.82%
5 year return (CAGR)
-63.19%
10 year return (CAGR)
-40.51%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.78M
Price/Sales
-
Ent value
4.25M
Price/Book
0.27
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-60.33%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.67 |
| Daily high | 3.80 |
| Daily low | 3.45 |
| Daily Volume | 15K |
| All-time high | 3232.80 |
| 1y analyst estimate | 12.00 |
| Beta | 0.68 |
| EPS (TTM) | -2.04 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| GLMD | S&P500 | |
| Current price drop from All-time high | -99.89% | -1.38% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 8 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -74.94% | -10.68% |
| Avg time to new high | 525 days | 12 days |
| Max time to new high | 2080 days | 1805 days |
News
No items found